Literature DB >> 19784409

Petrous apex cholesterol granuloma presenting as endolymphatic hydrops: a case report.

Ho Chan Kim1, Yun Suk An, Joong Ho Ahn.   

Abstract

A petrous apex cholesterol granuloma (PACG) is the most common lesion of the petrous apex mass. Affected patients present with various symptoms such as hearing loss, vertigo, headache, tinnitus, facial spasms, and diplopia. We report the case of a 32-yr-old man with a PACG, who was first misdiagnosed with Ménière's disease. He was placed on a low-salt diet, and prescribed medication from another hospital, for several months, but the symptoms persisted and worsened. The patient presented to the emergency room complaining of left facial twitching and numbness. To rule out a central neurological lesion, temporal bone magnetic resonance imaging was carried out and a 2.5 cm mass with high signal intensity on T1- and T2-weighted imaging, without gadolinium enhancement, was found. Because of the hearing and facial problems, we drained cholesterol-bearing material via an infralabyrinthine approach using a computer aided image-guided surgical device, the BrainLAB(R). After the operation, the vertigo and hearing loss were no longer present. It is likely that the patent's Ménière's disease-like symptoms were due to the compression of the endolymphatic sac by a PACG.

Entities:  

Keywords:  Cholesterol granuloma; Endolymphatic hydrops; Petrous apex

Year:  2009        PMID: 19784409      PMCID: PMC2751881          DOI: 10.3342/ceo.2009.2.3.151

Source DB:  PubMed          Journal:  Clin Exp Otorhinolaryngol        ISSN: 1976-8710            Impact factor:   3.372


  12 in total

Review 1.  Lesions of the petrous apex: diagnosis and management.

Authors:  Brandon Isaacson; J Walter Kutz; Peter S Roland
Journal:  Otolaryngol Clin North Am       Date:  2007-06       Impact factor: 3.346

Review 2.  Meniere's disease.

Authors:  Hamed Sajjadi; Michael M Paparella
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

3.  Diagnostic value of combining bilateral electrocochleography results for unilateral Ménière's disease.

Authors:  J H Hwang; H C Ho; C J Hsu; W S Yang; T C Liu
Journal:  Audiol Neurootol       Date:  2008-06-05       Impact factor: 1.854

4.  Petrous apex cholesterol granulomas: evolution and management.

Authors:  M B Eisenberg; G Haddad; O Al-Mefty
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

5.  Petrous apex lesions.

Authors:  R P Muckle; A De la Cruz; W M Lo
Journal:  Am J Otol       Date:  1998-03

6.  The long-term follow-up of drainage procedures for petrous apex cholesterol granulomas.

Authors:  B P Fong; D E Brackmann; F F Telischi
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-04

7.  Surgical management of petrous apex cholesterol granulomas.

Authors:  Derald E Brackmann; Elizabeth H Toh
Journal:  Otol Neurotol       Date:  2002-07       Impact factor: 2.311

8.  Image guided surgery for petrous apex lesions.

Authors:  T Van Havenbergh; E Koekelkoren; D De Ridder; P Van De Heyning; J Verlooy
Journal:  Acta Neurochir (Wien)       Date:  2003-09       Impact factor: 2.216

9.  A new theory to explain the genesis of petrous apex cholesterol granuloma.

Authors:  Robert K Jackler; Michael Cho
Journal:  Otol Neurotol       Date:  2003-01       Impact factor: 2.311

10.  Cholesterol granuloma of the petrous apex: benefit of computer-aided surgery.

Authors:  Marco Caversaccio; Eugène Panosetti; Panagiotis Ziglinas; Anton Lukes; Rudolf Häusler
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-06-10       Impact factor: 2.503

View more
  2 in total

1.  Perspectives in vestibular diagnostics and therapy.

Authors:  Arneborg Ernst
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

2.  Giant cholesterol granuloma of petrous apex.

Authors:  Ilir Ahmetgjekaj; Edlira Harizi; Abdur Rahman; Fjolla Hyseni; Fareeha Nasir; Arlind Decka; Masum Rahman; Kledisa Shemsi; Kristi Saliaj; Samar Akram; Ina Kola; Juna Musa
Journal:  Radiol Case Rep       Date:  2022-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.